Skip to main content

Articles By Jack Cush, MD

RheumNow Podcast square

Pre-ACR25 (10.24.2025)

Dr. Jack Cush reviews the news and info reports the day before ACR 2025

Read Article
CNS.demyelinating.jpg

Clinical and Genetic Effects of Neuropsychiatric Lupus

The clinical features and genetic abnormalities of neuropsychiatric systemic lupus erythematosus shows that NPSLE often means more severe lupus and more organ involvement beyond the central nervous system.

Read Article
PMR2.jpg

REPLENISH - Secukinumab Works in Polymyalgia Rheumatica

Novartis announced the results of their REPLENISH trial showing the efficacy of secukinumab in adults with polymyalgia rheumatica (PMR).

Read Article
pill,ASA,colchcine,small

Colchicine Ineffective in Long COVID

Management of long COVID has been perplexing with symptoms having functional and possibly inflammatory origins. Colchicine has been studied in long COVID and failed to improve functional capacity, respiratory function, or inflammatory markers. 

Read Article
autoimmune.disease

SGLT-2 inhibitors and the prevention of autoimmune rheumatic disease

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors have benefits beyond glycemic control, including cardioprotective and nephroprotective effects, with modest weight loss.

Read Article
FDA%20approved2.jpg

FDA Approves Obinutuzumab for Active Lupus Nephritis

The FDA has approved obinutuzumab (Gazyva) for the treatment of lupus nephritis. This is good news for the more than 1.7 million people worldwide with lupus nephritis.

Read Article
RheumNow Podcast square

Bad Actor Cofactor (10.17.2025)

Dr. Jack Cush reviews the news and journal reports, discusses pediatric reports, pregnancy data, diet and nutrition and more.

Read Article
lupus_0.jpg

Telitacicept Effective in Systemic Lupus Erythematosus

The NEJM has published a report from van Vollenhoven et al showing a new dual B cell inhibitor, telitacicept, to be effective when given to active systemic lupus erythematosus (SLE) patients; but this comes with a few safety concerns.

Read Article
ILD.colors

SAIL-RA: Finding ILD in Early RA

Cohort study of early rheumatoid arthritis (RA) patients finds that interstitial lung disease (ILD) begins early in the course of RA, with certain factors enhancing this risk.

Read Article
PSS.skin.Biopsy.Bx

Skin Biopsies to Predict Scleroderma Outcomes?

Researchers from the Hospital for Special Surgery and Weill Cornell Medicine have shown that skin biopsies in patients with systemic sclerosis (SSc) can define a fibroblast immunophenotype that may have prognostic and early treatment decision impact.

Read Article
×